Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S)-26-((1H-imidazol-5-yl)methyl)-44-amino-20-(2-amino-2-oxoethyl)-8-benzyl-17-sec-butyl-29,38-bis(3-guanidinopropyl)-32-((R)-1-hydroxyethyl)-11,14,41-triisobutyl-23-isopropyl-35,45-dimethyl-5-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaazahexatetracontan-1-oic acid
ID: ALA4475768
PubChem CID: 155537704
Max Phase: Preclinical
Molecular Formula: C79H134N24O18S
Molecular Weight: 1740.16
Molecule Type: Unknown
Associated Items: